Evidence map›Paper›PMID 31815338›Full record

ArticleThe FEBS journal2020

High intracellular stability of the spidroin N-terminal domain in spite of abundant amyloidogenic segments revealed by in-cell hydrogen/deuterium exchange mass spectrometry.

Margit Kaldmäe, Axel Leppert, Gefei Chen, Medoune Sarr, Cagla Sahin, Kerstin Nordling, Nina Kronqvist, Marta Gonzalvo-Ulla, Nicolas Fritz, Axel Abelein and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 3 countries.

Margit KaldmäeDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Biomedicum, Solna, Sweden.
Axel LeppertDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Gefei ChenDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Medoune SarrDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Cagla SahinDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Biomedicum, Solna, Sweden.
Kerstin NordlingDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Nina KronqvistDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Marta Gonzalvo-UllaDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Biomedicum, Solna, Sweden.
Nicolas FritzDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Biomedicum, Solna, Sweden.ORCID 0000-0002-9722-7425
Axel AbeleinDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Sonia LaίnDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Biomedicum, Solna, Sweden.
Henrik BiverstålDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Hans JörnvallDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Biomedicum, Solna, Sweden.
David P LaneDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Biomedicum, Solna, Sweden.
Anna RisingDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.
Jan JohanssonDepartment of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-8719-4703
Michael LandrehDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Biomedicum, Solna, Sweden.ORCID 0000-0002-7958-4074
Karolinska Institutet · SECalifornia Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteins require an optimal balance of conformational flexibility and stability in their native environment to ensure their biological functions. A striking example is spidroins, spider silk proteins, which are stored at extremely high concentrations in soluble form, yet undergo amyloid-like aggregation during spinning. Here, we elucidate the stability of the highly soluble N-terminal domain (NT) of major ampullate spidroin 1 in the Escherichia coli cytosol as well as in inclusion bodies containing fibrillar aggregates. Surprisingly, we find that NT, despite being largely composed of amyloidogenic sequences, showed no signs of concentration-dependent aggregation. Using a novel intracellular hydrogen/deuterium exchange mass spectrometry (HDX-MS) approach, we reveal that NT adopts a tight fold in the E. coli cytosol and in this manner conceals its aggregation-prone regions by maintaining a tight fold under crowded conditions. Fusion of NT to the unstructured amyloid-forming Aβ

Indexed as

Amino Acid SequenceAmyloidAmyloidogenic ProteinsAnimalsBinding SitesCrystallography, X-RayFibroinsHydrogen Deuterium Exchange-Mass SpectrometryHydrogen-Ion ConcentrationModels, MolecularProtein BindingProtein ConformationProtein MultimerizationSpidersAmyloidAmyloidogenic ProteinsFibroinsspidroin 1hydrogen/deuterium exchange mass spectrometryintracellular protein foldingprotein aggregationspider silk

Identifiers

PMID31815338
PMCPMC7383493
OpenAlexW2996427427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.